A Phase I Multiple Administration Study of TAK-448 in Patients with Prostate Cancer
Latest Information Update: 27 May 2016
At a glance
- Drugs MVT 602 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Takeda
- 27 May 2016 New trial record